AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Roza 6.25mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Events Pharma

Salt Composition

Zolpidem (6.25mg)

Overview Roza 6.25mg Tablet ER

Sonata 6.25mg Extended-Release tablets are indicated for short-term insomnia relief. They shorten sleep latency and reduce nocturnal awakenings, promoting consolidated sleep. Administer Sonata 6.25mg ER on an empty stomach, ideally just before bedtime, consistently at the same time daily for optimal therapeutic levels. Adhere strictly to your physician's prescribed dosage and duration; this medication can be habit-forming and should not be discontinued abruptly without medical consultation, as withdrawal may exacerbate symptoms. Potential side effects include, but are not limited to: cognitive impairment, visual disturbances, restlessness, cephalalgia, dizziness, gastrointestinal upset (nausea, vomiting, diarrhea), myalgia, and depressive symptoms. These are typically transient; however, persistent or bothersome effects warrant immediate medical attention. Due to its sedative properties, avoid operating machinery or engaging in activities requiring alertness until the drug's effects are understood. Alcohol consumption is strongly discouraged. Report any unusual behavioral changes, worsening depression, psychotic symptoms, or suicidal ideation to your doctor promptly. Prior to initiating Sonata 6.25mg ER, disclose all current medications to your doctor for compatibility assessment. Individuals with hepatic or renal impairment should consult their physician before use. Smoking and alcohol should be avoided during treatment. This medication is contraindicated during pregnancy and lactation; consult your doctor if use becomes necessary.

Primary Ingredients of Roza 6.25mg Tablet ER

No text provided to rephrase.

Uses of Roza 6.25mg Tablet ER

Managing Sleep Difficulties

Major Benefits of Roza 6.25mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 6.25mg Roza Extended-Release tablet whole; do not crush, chew, or break it. Administer on an empty stomach.

Common Side effects of Roza 6.25mg Tablet ER:

  • Dizziness
  • Sleepiness
  • Headache
  • Nausea
  • Stomach pain
  • Memory loss
  • Vertigo
  • Vomiting
  • Back pain
  • Agitation
  • Double vision
  • Depression

How to use Roza 6.25mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Roza 6.25mg Extended-Release Tablet whole; do not chew, crush, or fracture it. Administer on an empty stomach.

How Roza 6.25mg Tablet ER works:

Roza 6.25mg Extended-Release Tablets are classified as non-benzodiazepine sleep aids. Possessing hypnotic, sedative, and anticonvulsant effects (controlling seizures), this medication functions by interacting with the GABAA receptor chloride channel complex—a neurotransmitter—to reduce neuronal activity in the brain, thus promoting sleep onset.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Roza 6.25mg extended-release tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Roza 6.25mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Roza 6.25mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Roza 6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Roza 6.25mg tablets are considered safe for use in individuals with kidney impairment; no dosage modification is typically necessary. Nevertheless, disclosure of any existing kidney condition to your physician is advised.

LiverLiverCAUTION

Individuals with liver impairment should use Roza 6.25mg Extended-Release tablets cautiously. Dosage modification of Roza 6.25mg Extended-Release tablets may be necessary. Medical advice is recommended. For those with mild to moderate liver disease, Roza 6.25mg Extended-Release tablets are typically initiated at a reduced dosage; however, they are contraindicated in patients with severe liver disease.

What if you forget to take Roza 6.25mg Tablet ER :

Omit any missed Roza 6.25mg Extended-Release Tablet and resume your regular dosing regimen. Avoid taking a double dose.

Facts to Know About Roza 6.25mg Tablet ER

LabelValue
Chemical Type Imidazopyridine Compound
Developing Habits Affirmative.
Treatment Category Neuroscience Central Nervous System
Actions Non-benzodiazepine sleeping medications (Z-drugs)

FAQs on Roza 6.25mg Tablet ER

Roza 6.25mg Extended-Release tablets promote calmness and sleep. Some users may experience this as euphoria. However, long-term use can lead to dependence, making it difficult to sleep or function normally without the medication.
Roza 6.25mg Tablet ER has a potential for abuse, particularly among individuals with a history of substance abuse or addiction. Physicians should diligently assess patients' substance abuse history, and those with such a history require close monitoring during treatment with Roza 6.25mg Tablet ER.
Roza 6.25mg ER tablets haven't shown drug interactions with prednisone, but always check with your doctor before combining them.
Roza 6.25mg Extended-Release tablets treat insomnia; this may incidentally alleviate anxiety in some individuals. However, it's not prescribed solely for anxiety due to its differing mechanism of action compared to other sedative-anxiolytics.
Overdosing on Roza 6.25mg Tablet ER may cause drowsiness, confusion, poor coordination, muscle weakness, slowed or labored breathing, and coma.
Roza 6.25mg Extended-Release Tablets may cause daytime drowsiness and reduced alertness. Avoid driving or operating machinery until you understand how this medication affects you. Refrain from alcohol consumption while taking Roza 6.25mg Extended-Release Tablets, as it can worsen side effects.
Do not take Roza 6.25mg Tablet ER if you are allergic to it or its ingredients, have a history of depression, mental illness, suicidal thoughts, drug or alcohol abuse/addiction, kidney or liver disease, lung disease, or breathing problems. It is also not recommended during pregnancy, while planning pregnancy, or if breastfeeding.
Avoid taking Roza 6.25mg Tablet ER with or immediately after a large, high-fat meal; its effectiveness may be reduced.
Roza 6.25mg Extended-Release tablets treat short-term insomnia (difficulty sleeping) for 2–4 weeks. Always follow your doctor's instructions precisely; exceeding the prescribed dose or duration may cause dependence.
Dry mouth is a frequent side effect of Roza 6.25mg Tablet ER, while weight gain is less frequent. Increased appetite may contribute to any weight gain experienced.
Roza 6.25mg ER tablets take effect immediately and can cause significant drowsiness. Expect prolonged sleepiness after taking it. Therefore, only take this medication if you can go to bed immediately and sleep for 7–8 uninterrupted hours.
Always consult your doctor before discontinuing Roza 6.25mg Tablet ER. Abruptly stopping this medication may cause withdrawal, including discomfort, stomach and muscle cramps, vomiting, sweating, tremors, and in rare cases, seizures.
Enhance your sleep by avoiding caffeine and nicotine, particularly in the evening. Refrain from exercising within four hours of bedtime, although regular exercise is beneficial for sleep. Avoid heavy evening meals and daytime naps. Maintain a consistent sleep schedule, ensuring you go to bed and wake up at the same time daily. Create a dark, comfortably cool bedroom environment. Incorporate a relaxing bedtime routine using relaxation techniques.
Insomnia, a prevalent sleep disorder, is characterized by difficulty falling asleep, staying asleep, or both. This often leads to insufficient or poor-quality sleep, resulting in a lack of restorative rest upon waking.
Insomnia is classified as primary or secondary. Primary insomnia has no identifiable cause, often stemming from lifestyle factors like prolonged stress and emotional distress. Secondary insomnia, conversely, arises from various factors including underlying medical conditions (e.g., depression, anxiety, PTSD, Alzheimer's, Parkinson's), medications, other sleep disorders, and substance use (e.g., caffeine, nicotine, alcohol).
Roza 6.25mg Tablet ER
112
MRP 130
13% off